Recombinant Replacement Therapy for Hereditary Angioedema Due to C1 Inhibitor Deficiency

Abstract excerpt

Hereditary angioedema is a rare genetic condition transmitted as an autosomal dominant trait and characterized most commonly by the production of either inadequate or nonfunctioning C1 esterase inhibitor (C1-INH), a blood protein that regulates proteases in the complement, fibrinolytic and contact systems. Patients with hereditary angioedema suffer from episodic, unpredictable manifestations of edema affecting...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoimmune Bullous Skin Diseases
• Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
• Share to Vitamin K Research Studies